


Anti-CDK6 Recombinant Antibody Products

Anti-CDK6 Products
- Rabbit Anti-CDK6 Recombinant Antibody (clone CBACN-141) (MRO-0343-CN)
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IF, IHC, FC
- Rabbit Anti-CDK6 Polyclonal Antibody (MRO-1768-CN) (MRO-1768-CN)
-
- Species Reactivity: Human, Mouse, Rat
- Type: Rabbit IgG
- Application: WB, IF, IHC
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, IP, IHC
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, WB, IP
-
- Derivation: Rabbit
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC, FC
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, ICC, IF
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, IF, IHC
- Recombinant Mouse Anti-Human CDK6 Antibody (MOB-2477MZ)
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: ICC/IF, IHC-P, WB
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, ICC, FC
- Anti-CDK6 Immunohistochemistry Kit (VS-0325-XY408)
-
- Species Reactivity: Human, Mouse, Rat
- Target: CDK6
- Application: IHC
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC-P, FC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs provides an extensive lineup of superior anti-CDK6 antibodies that are engineered to suit the stringent requirements of current scientific research. We offer exceptional customer support to ensure a seamless research experience. By collaborating with Creative Biolabs, you have access to cutting-edge technologies that will help you advance your scientific research and contribute to revolutionary discoveries.
CDK6: A New Frontier in Cancer Treatment
CDK6, a protein kinase, is essential for transcriptional regulation in tumor and hematopoietic stem cells. This suggests a role in maintaining tissue homeostasis and differentiation, which is partially independent of CDK6's kinase activity and distinguishes it from CDK4. Furthermore, the frequent dysregulation of CDK6 and its associated G1 phase regulators in a vast majority of cancers underscores its significance in tumorigenesis. As such, targeting CDK6 has emerged as a promising avenue for the development of effective cancer treatments.
Alternative Names
Cyclin-dependent kinase 6; cell division protein kinase 6; PLSTIRE; MCPH12
Background
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2.
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins
Intracellular
Cell type enhanced (Late spermatids, Oligodendrocytes, Early spermatids, Erythroid cells)
Not detected in immune cells
Cell line enhanced (MOLT-4, REH)
Interaction with D-type G1 cyclins. Cyclin binding promotes enzyme activation by phosphorylation at Thr-177 (By similarity). Binds to RUNX1, CDKN2D, FBXO7 and CDKN2C/p18-INK4c. Forms a cytoplasmic complex with Hsp90/HSP90AB1 and CDC37. FBXO7-binding promotes D-type cyclin binding. Interacts with Kaposi's sarcoma herpesvirus (KSHV) V-cyclin and herpesvirus saimiri (V-cyclin/ECLF2); the CDK6/V-cyclin complex phosphorylates NPM1 and thus lead to viral reactivation by reducing viral LANA levels.
Kinase, Serine/threonine-protein kinase, Transferase
Anti-CDK6 rAb Products
Creative Biolabs' anti-CDK6 antibodies are engineered to precisely target CDK6 with exceptional efficiency, specificity, and potency, ensuring minimal interference with non-target proteins. Furthermore, the availability of diverse antibody formats empowers researchers to select the optimal antibody for your specific applications, broadening the scope of your scientific investigations.
Table 1. Featured anti-CDK6 recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
VS3-FY349 | Recombinant Rabbit Anti-CDK6 Antibody (clone R03-2G5) | Human | Rabbit IgG | WB, IHC, IF |
ZG-0614J | Rabbit Anti-CDK6 Recombinant Antibody (clone 8G3) | Human | Rabbit IgG | ELISA, WB, IP |
MRO-0343-CN | Rabbit Anti-CDK6 Recombinant Antibody (clone CBACN-141) | Human | Rabbit IgG | WB, IF, IHC, FC |
MOB-2477MZ | Recombinant Mouse Anti-Human CDK6 Antibody | Human | Mouse antibody | ICC/IF, IHC-P, WB |
MRO-1768-CN | Rabbit Anti-CDK6 Polyclonal Antibody | Human, Mouse, Rat | Rabbit IgG | WB, IF, IHC, etc. |
Creative Quality Control
Creative Biolabs is committed to empowering researchers with a comprehensive collection of high-quality anti-CDK6 antibodies. Each antibody undergoes rigorous quality control to ensure exceptional performance across diverse applications. Our unwavering dedication to excellence guarantees that our products meet the industry's most stringent standards, providing reliable and consistent results to support your scientific endeavors.
Fig.1 WB analysis of anti-CDK6 antibody
(Cat# VS3-FY349, Creative Biolabs).
Fig.2 WB analysis of anti-CDK6 antibody
(Cat# ZG-0614J, Creative Biolabs).
Fig.3 IP analysis of anti-CDK6 antibody
(Cat# ZG-0614J, Creative Biolabs).
Customer Reviews

Rabbit Anti-CDK6 Recombinant Antibody (clone 8G3) (ZG-0614J)

Rabbit Anti-CDK6 Polyclonal Antibody (MRO-1768-CN) (MRO-1768-CN)

Rabbit Anti-CDK6 Recombinant Antibody (clone 8G3) (ZG-0614J)
rAb Production
Creative Biolabs' cutting-edge recombinant antibody platform incorporates innovative genetic engineering techniques to produce outstanding anti-CDK6 antibodies. This novel technique guarantees efficient and adaptable manufacturing, ensuring a steady supply of antibodies to fulfill the unique needs of researchers across several scientific categories.
Featured Anti-CDK6 Recombinant Antibody Production Platforms
Fig.4 Milligram-scale anti-CDK6 recombinant antibody production.
Fig.5 Gram-scale anti-CDK6 recombinant antibody production.
rAb Modalities
Creative Biolabs provides an extensive option of top-notch anti-CDK6 recombinant antibodies in a variety of forms to meet your individual research requirements.
Fig.6 Full-length anti-CDK6 recombinant antibody production and modalities.
CDK6-Targeted Drug Information
Table 2. Public drug targeting CDK6.
Highest Phase | Mechanism of Action | Product Category | Condition | Organization |
Launched - 2017 |
Aromatase (CYP19A1) Inhibitors Cyclin-Dependent Kinase 4 (CDK4) Inhibitors Cyclin-Dependent Kinase 6 (CDK6) Inhibitors Signal Transduction Modulators |
Cancer Hormone Therapy Multi-Component Products Radiosensitizers |
Cancer, breast | Novartis (Originator) |
Phase I/II |
Cyclin-Dependent Kinase 4 (CDK4) Inhibitors Signal Transduction Modulators |
Peptides |
Cancer, bladder Cancer, colorectal Digestive-gastrointestinal cancer Glioblastoma multiforme Melanoma |
MetaMax (Originator) |
IND Filed |
Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers Drugs Targeting Protein Cereblon (CRBN) Signal Transduction Modulators |
PROTACs (Proteolysis Targeting Chimeras) |
Cancer, breast Cancer, solid tumor |
BioTheryX (Originator) |
Preclinical |
Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers Drugs Targeting Von Hippel-Lindau Disease Tumor Suppressor (VHL) Signal Transduction Modulators |
Oligopeptides, less than 10 AA PROTACs (Proteolysis Targeting Chimeras) |
Cancer | Icahn School of Medicine at Mount Sinai (Originator) |
Biological Testing |
CDK4/Cyclin D3 Inhibitors CDK6/Cyclin D3 Inhibitors Cyclin-Dependent Kinase 4 (CDK4) Inhibitors Cyclin-Dependent Kinase 6 (CDK6) Inhibitors Drugs Targeting EGFR (HER1; erbB1) Signal Transduction Modulators |
Antibody-Drug Conjugates (ADCs) Cancer Immunotherapy Chimeric Monoclonal Antibodies |
Cancer | Yonsei University (Originator) |
Biological Testing |
Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers Drugs Targeting Inhibitor of Apoptosis Proteins (IAP) Signal Transduction Modulators |
Oligopeptides, less than 10 AA PROTACs (Proteolysis Targeting Chimeras) SNIPERs (Specific and Nongenetic IAP-Dependent Protein Eraser) |
Cancer | GSK (Originator) |
Biological Testing |
Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers Drugs Targeting Von Hippel-Lindau Disease Tumor Suppressor (VHL) Signal Transduction Modulators |
Oligopeptides, less than 10 AA PROTACs (Proteolysis Targeting Chimeras) |
Cancer | GSK (Originator) |
Biological Testing |
Cyclin-Dependent Kinase 4 (CDK4) Inhibitors Cyclin-Dependent Kinase 6 (CDK6) Inhibitors Signal Transduction Modulators |
Polypeptides, from 10 AA to 40 AA | Cancer | Cyclacel (Originator) |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Creative Biolabs, a leader in antibody research, leverages a robust theoretical framework and extensive practical experience to provide affordable, high-quality anti-CDK6 antibodies. To learn more about our anti-CDK6 antibody products and how they can support your research, please don't hesitate to contact us.